Skip to content

Neuronetics STIM Product — Cost of Goods Sold

Other product segments

Service
$15.44M+18.0%

Similar metrics at other companies

Outset Medical, Inc. logo
OMProduct — Cost of Goods Sold
$8.83M-19.7%
LQD
LQDAProduct — Cost of Goods Sold
$11.08M
FuelCell Energy logo
FCELProduct — Cost of Goods Sold
$20.28M+24.7%
Innoviva, Inc. logo
INVAProduct — Cost of Goods Sold
$15.61M+76.5%
Verra Mobility logo
VRRMProduct — Cost of Goods Sold
$8.29M+3.2%
Agilysys logo
AGYSProduct — Cost of Goods Sold
$6.17M+1.5%

Other financials

Income statement

See full
Revenue$34.5M+7.8%
Gross profit$16.2M+2.6%
Operating income-$9.0M+18.3%
Net income-$10.8M+14.9%
EPS (diluted)-$0.16+23.8%

Balance sheet

See full
Cash & equivalents$13.2M-34.7%
Total debt$85.4M+3.5%
Total equity$13.3M-62.6%
Total assets$125.4M-11.7%

Cash flow

See full
Operating cash flow-$9.4M+44.6%
CapEx$197.0K-10.0%
Free cash flow-$9.6M+44.1%

Valuation

See full
Market cap$90.46M-59.6%
Enterprise value$162.64M-44.6%
P/S0.6×-1.4×

Profitability

See full
Gross margin48%-15.6pp
Operating margin-19.4%-6.9pp
Net margin-24.5%-8.7pp
FCF margin-9.4%-4.1pp

Returns & leverage

See full
Return on equity-152.4%-1.4pp
Debt / equity6.4×+4.1×
Current ratio1.7×-0.8×

Where this comes from

Reported directly by Neuronetics in its filing.

Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.

The official record: Neuronetics’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Neuronetics's product — cost of goods sold.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Neuronetics's product — cost of goods sold?
Neuronetics (STIM) reported product — cost of goods sold of $2.86M in Q1 2026.
How has Neuronetics's product — cost of goods sold changed year-over-year?
Neuronetics's product — cost of goods sold decreased by 9.3% year-over-year, from $3.15M to $2.86M.
What does product — cost of goods sold mean?
This metric captures the direct costs associated with the manufacturing, assembly, and delivery of the company's medical technology products. It includes expenses such as raw materials, direct labor, and overhead costs directly attributable to the production of the therapeutic systems. Monitoring this cost provides insight into the company's manufacturing efficiency and the direct margin profile of its product segment.